Acute Erythroid Leukemia - 171 Studies Found
| Completed |
: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia :
|
| Completed |
: Vorinostat in Treating Patients With Acute Myeloid Leukemia :
|
| Completed |
: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia :
|
| Terminated |
: AML Therapy With Irradiated Allogeneic Cells :
|
| Active, not recruiting |
: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
| Terminated |
: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
| Active, not recruiting |
: Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
| Active, not recruiting |
: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay :
|
| Active, not recruiting |
: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML :
|